Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
Vaccination against neo-antigens has resulted in an effective antitumor response in several models. Here, the authors show that delivery of larger sets of neo-antigens using an adenovirus-based vaccination platform, results in much better tumor protection when combined with checkpoint blockade in a...
Saved in:
Main Authors: | Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Francesca Langone, Imma Fichera, Maria De Lucia, Lidia Avalle, Rosa Vitale, Adriano Leuzzi, Veronica Bignone, Elena Di Matteo, Fabio Giovanni Tucci, Valeria Poli, Armin Lahm, Maria Teresa Catanese, Antonella Folgori, Stefano Colloca, Alfredo Nicosia, Elisa Scarselli |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/db93e80d193c417e9e00b2880fe30cbc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
by: Margherita Passariello, et al.
Published: (2019) -
Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions
by: Labib BA, et al.
Published: (2020) -
EPIDEMIOLOGY OF ADENOVIRAL INFECTION IN ST. PETERSBURG
by: I. V. Ovsyannikova, et al.
Published: (2018) -
Neoantigens elicit T cell responses in breast cancer
by: Takafumi Morisaki, et al.
Published: (2021) -
Protein citrullination as a source of cancer neoantigens
by: Makoto Kobayashi, et al.
Published: (2021)